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Abstract
Background: A high percentage of abortions performed in South Africa are in the second trimester. However, little
research focuses on women’s experiences seeking second trimester abortion or the efficacy and safety of these
services.
The objectives are to document clinical and acceptability outcomes of second trimester medical and surgical
abortion as performed at public hospitals in the Western Cape Province.
Methods: We performed a cross-sectional study of women undergoing abortion at 12.1-20.9 weeks at five
hospitals in Western Cape Province, South Africa in 2008. Two hundred and twenty women underwent D&E with
misoprostol cervical priming, and 84 underwent induction with misoprostol alone. Information was obtained about
the procedure and immediate complications, and women were interviewed after recovery.
Results: Median gestational age at abortion was earlier for D&E clients compared to induction (16.0 weeks vs. 18.1
weeks, p < 0.001). D&E clients reported shorter intervals between first clinic visit and abortion (median 17 vs. 30
days, p < 0.001). D&E was more effective than induction (99.5% vs. 50.0% of cases completed on-site without
unplanned surgical procedure, p < 0.001). Although immediate complications were similar (43.8% D&E vs. 52.4%
induction), all three major complications occurred with induction. Early fetal expulsion occurred in 43.3% of D&E
cases. While D&E clients reported higher pain levels and emotional discomfort, most women were satisfied with
their experience.
Conclusions: As currently performed in South Africa, second trimester abortions by D&E were more effective than
induction procedures, required shorter hospital stay, had fewer major immediate complications and were
associated with shorter delays accessing care. Both services can be improved by implementing evidence-based
protocols.
Background
Both medical and surgical abortion procedures are used
in the second trimester. Intra-amniotic instillation pro-
cedures are no longer recommended because they are
associated with more complications than other proce-
dures [1]. Modern medical methods include induction
with mifepristone and misoprostol or with misoprostol
alone. The combined mifepristone regimen is signifi-
cantly more effective and results in a shorter induction
time than misoprostol used alone [2]. In South Africa,
misoprostol alone is currently the standard of care for
medical termination of pregnancy in the second trime-
ster within the public health sector. Dilation and
evacuation (D&E) is the surgical method recommended
by the World Health Organization [3].
The few studies that have compared medical and sur-
gical second trimester abortion techniques all have been
conducted in developed country contexts [4-8]. One
small randomized controlled trial (RCT) comparing
D&E to the mifepristone regimen at 14-19 weeks’ gesta-
tion in the United States (U.S.) found that women
undergoing medical induction had a higher risk of com-
plications (RR 6.0, 95% CI 0.9-40.3) [6]. Another RCT in
t h eU n i t e dK i n g d o mf o u n dt h a tc o m p l i c a t i o n sw e r e
similar between the two methods, although women
undergoing medical induction reported more pain and
found the procedure less acceptable compared to those
undergoing D&E [5]. A retrospective audit of second-tri-
mester procedures at one facility in New Zealand found
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significantly more common among women undergoing
medical induction [4]. Another retrospective cohort
study from the U.S. of women undergoing D&E or med-
ical induction, mostly with misoprostol used alone,
found that adverse events were significantly more com-
mon among medical induction patients (29% vs. 4%, p <
0.001) [7]. In particular, failure of initial procedure and
retained tissue requiring curettage were more common
with medical induction. In a retrospective cohort study
of U.S. women seeking termination for fetal anomalies,
the adjusted risk ratio of having any complication was
significantly higher for women undergoing induction
with misoprostol compared to D&E (RR 8.5, 95% CI
3.7-19.8) [8]. A recent review of large case series of sec-
ond trimester abortion procedures also found that medi-
cal induction with the mifepristone regimen was
associated with a higher proportion of incomplete abor-
tions, as well as a possible higher risk of hemorrhage
requiring transfusion and mild infection, compared with
D&E [9].
Information about the safety and efficacy of these termi-
nation methods is particularly relevant in countries that
are beginning to scale up second trimester services. The
Choice on Termination of Pregnancy Act was passed in
1996 in South Africa, allowing abortion up to 12 weeks’
gestation on request; termination up to 20 weeks is legal
for several indications, including socio-economic hardship
[10]. Approximately 25% of abortions in South Africa are
performed after 12 weeks [11], whereas in most developed
countries approximately 10% of abortions are in the sec-
ond trimester [12,13]. Most second trimester abortions in
South Africa are performed by medical induction with
misoprostol alone, although in Western Cape Province, a
roving team of three doctors provides D&E in the public
sector [14] Due to the lack of trained D&E providers in
other areas of the country, hysterotomy is sometimes per-
formed in cases of failed induction [15].
The objective of this study was to describe women’s
experiences seeking and undergoing second trimester
abortion at public sector hospitals in Western Cape Pro-
vince, including documenting the efficacy, safety and
acceptability of medical and surgical abortion as cur-
rently performed.
Methods
We performed a cross-sectional study of women under-
going either D&E or second trimester medical induction
with misoprostol alone. We investigated access to and
acceptability of D&E and medical induction by inter-
viewing women after completion of their abortion.
Length of procedure, medications used, safety and effi-
cacy were compared using clinical information collected
during or after the procedure.
T h es t u d yw a sa p p r o v e db yt h eU n i v e r s i t yo fC a p e
Town Research Ethics Committee, Stellenbosch Univer-
sity Committee for Human Research and Allendale
Investigational Review Board. Permission to perform the
research was obtained from the Provincial Department
of Health, Western Cape. All participants provided writ-
ten informed consent, and confidentiality and anonymity
were ensured. Study procedures were carried out in
accordance with the revised version of the Helsinki
Declaration and with the standards of Good Clinical
Practice.
The study was conducted between February and July
2008 at five public sector hospitals in Western Cape
Province, South Africa. These sites were five of the nine
public hospitals in the province that provided second
trimester abortion services, either by D&E or medical
induction, during the study period. The remaining four
hospitals performing second trimester abortion were not
included in the study due to logistical reasons which
included distance, low volume and permission being
denied at one facility. Women generally were referred to
these hospitals based on regional proximity, and clients
were not offered a choice of which facility to attend. No
hospital offered both D&E and medical induction, and
therefore women did not have a choice of abortion
method after presenting to the facility.
Three of the study hospitals offered outpatient D&E
services, and the other two offered medical induction on
an inpatient basis. Of the five sites, two D&E sites and
one induction site served a primarily urban population,
while the other sites served a more peri-urban and rural
population. We collected data at each site on the total
number of second trimester abortions performed during
the study period by reviewing logs of abortion proce-
dures maintained at the facilities.
All women attending these hospitals for second trime-
ster abortion on days when study interviewers were pre-
sent were invited to participate in the study. Eligibility
was assessed prior to the abortion, and criteria included
age 18 years or older, gestational age between 12.1
weeks and 20.9 weeks, and ability to communicate in
English or Xhosa. All participants provided written
informed consent before enrollment to both an inter-
view and hospital record review.
Bilingual interviewers administered structured ques-
tionnaires in a private location at the hospital after the
woman recovered from the abortion. Data were
obtained on age, spoken language, education, employ-
ment, housing conditions and reproductive history.
Information was also obtained about the number and
timing of clinic visits leading up to admission for the
current abortion. After initial data collection, the long
delay between date of the first clinic visit and date of
admission for the abortion as reported by the participant
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information was collected on the date and result of the
ultrasound scan from participants’ charts. Although the
ultrasound may not have been performed at the first
clinic visit, it was the only documented record of partici-
pants’ access to abortion-related care.
For details relating to the abortion experience itself,
clients were asked to rate the following on a 5-point
Likert scale: overall satisfaction with the abortion, pain
and emotional discomfort.
For participants undergoing medical induction, a pro-
cedure form was completed by the attending doctor or
by the study investigators following discharge of the par-
ticipant. Data were collected on gestational age by ultra-
sound, date of initial ultrasound, duration of procedure
(from first misoprostol dose to placental expulsion or
surgical procedure, if performed), duration of hospital
stay, timing and dosage of misoprostol and any other
medications, and details of additional surgery, if per-
formed. When forms were incomplete, participants’
medical records were reviewed. For participants under-
going D&E, the procedure form was completed by the
doctor performing the abortion immediately after the
procedure. Gestational age by ultrasound, duration of
surgical procedure, details of the procedure, and
whether fetal expulsion occurred prior to surgery were
noted. Because most of the relevant information on the
D&E procedure was not documented in the medical
record, it was not possible to collect this information
later if the form was incomplete.
The primary outcome of the study was procedure effi-
cacy, defined as complete abortion performed on site,
with no need for repeat surgical procedure in the case
of D&E, or no need for any surgical intervention in the
case of induction. Secondary outcomes included safety
and acceptability. Safety was assessed by measuring the
prevalence of immediate major complications (death,
seizure, injury to organ requiring abdominal surgery, or
hemorrhage requiring transfusion) or minor complica-
tions (hemorrhage without transfusion, fever, cervico-
vaginal trauma, transfer to another facility because of
inability to complete procedure, unplanned surgical pro-
cedure (for induction) and fetal expulsion prior to pro-
cedure (for D&E)) [16]. Because it was not standard at
these sites to have women return for a follow-up visit,
information on delayed complications was not available.
Acceptability was determined by overall satisfaction,
pain and emotional discomfort, and likelihood of recom-
mending the abortion method to others.
Data were analyzed using Stata (version 10, College
Station, TX). We summarized data on participant char-
acteristics, abortion-related hospital and clinic visits,
procedure details, efficacy, complications and acceptabil-
ity by abortion method using proportions for categorical
variables and medians for continuous variables. 95%
confidence intervals (CI) were calculated for propor-
tions, and proportions were compared using chi-square
tests or Fisher’se x a c tt e s t sw h e na p p r o p r i a t e .W h e r e
medians were compared, Wilcoxon rank sum tests were
used. Two-sided significance tests were used through-
out. Missing values were excluded from the analysis,
and valid percentages are reported for all results. Statis-
tical comparisons were performed by procedure rather
than by site as numbers were often too small to allow
for analysis by site.
The number of subjects recruited was sufficient to
detect a difference in efficacy between 85% for induction
and 98% for D&E, with 90% power and two-sided alpha
of 0.05.
Results
During the data collection period, 746 D&E and 168
second trimester medical inductions were performed at
the study sites. Two hundred twenty women undergoing
D&E (29.5% of all D&E cases) and 84 women under-
going medical induction (50% of all induction cases)
were enrolled in the study. Figure 1 demonstrates the
recruitment process, including the reasons why women
were not eligible. Participant characteristics, shown in
Table 1, were similar in both groups except for gesta-
tional age on admission (date of procedure for D&E and
date of hospital admission for medical induction) and
the proportion speaking Afrikaans. Median gestational
age for D&E clients was 15.0 weeks (inter-quartile range
(IQR) 14.0 - 16.6 weeks) and for induction clients was
Not willing to participate 
N = 73 
D & E 
N = 220 
Eligible and enrolled 
N=304 
Not Eligible 
N = 94 
 
Gestational age <13wks:  52 
Age < 18yrs: 29 
Language: 12 
Not able to consent: 1   
Eligibility 
Recruitment 
Willing to participate 
N = 398 
MI 
N = 84 
Women approached 
N = 471 
D & E 
N = 220 
MI 
N = 84 
Figure 1 Flowchart of participant enrollment.
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median age was 25 years; 51% had completed secondary
school, and just 6.5% had completed only grade 8 or
lower. Most women (80%) had one or more children,
and most (71%) had had a vaginal delivery, while 9%
had previously undergone a caesarian section. Few parti-
cipants (4%) reported having had a prior abortion. Sixty-
five percent were not paid for work, 65% lived in formal
housing (house or flat), as opposed to informal housing
(shack), and for most participants (79%) there were two
or fewer people per room in the place where they lived.
Xhosa was the most common language spoken at home
(69%), followed by English (26%) and Afrikaans (22%).
More D&E clients spoke Afrikaans at home, which was
likely related to the catchment areas of the hospitals.
Information about the number and timing of visits
prior to the abortion is shown in Table 2. The majority
of participants reported three or more clinic or hospital
visits related to the abortion, and induction clients
reported significantly more visits (p < 0.001). Substantial
delays occurred between the date of the first clinic visit
reported by the participant and the date of admission
for the abortion. The median delay was significantly
longer for induction clients (30 days, IQR 21-56 days)
than for D&E clients (17 days, IQR 8-30 days, p <
0.001). Based on the date of the reported visit, 40% of
D&E clients and 39% of induction clients were at 12
weeks’ gestation or earlier at the time of the first clinic
visit. Median gestational age at ultrasound was slightly
earlier for induction clients, and the time interval from
the date of the ultrasound to the date of admission was
significantly longer for induction clients (31 days, IQR
12-41) than for D&E clients (6 days, IQR 2-9, p <
0.001).
More induction clients than D&E clients were in the
first trimester at the time of their ultrasound (30.0% vs.
8.1%, p < 0.001). These data were available for 161 D&E
clients and 80 induction clients.
Table 3 shows information about the abortion proce-
dure, including complications, which was available for
203 D&E clients and 84 induction clients. The median
duration of the surgical procedure for D&E was 10 min-
utes (IQR 5 - 10 minutes), and median time from first
misoprostol dose to completion of D&E was 13.3 hours
(IQR 12.1 - 15.1 hours), with no overnight stays in hos-
pital. The median duration from first misoprostol dose
to completion of the induction procedure was 23 hours
(IQR 17 - 30 hours), and all but one woman required
an overnight stay in hospital. The median duration of
hospitalization for induction clients was 1.3 days (IQR
1.1-2.1 days), with a maximum hospital stay of 11.1
days.
Misoprostol was used to prepare the cervix prior to
D&E at the sites offering this method, although the regi-
men varied both between and within sites. An initial
dose of misoprostol 400 mcg was taken sublingually at
home either the night before or the morning of the
abortion procedure. Thereafter the dose was repeated at
four-hourly intervals, usually up to a total of three
doses. However, at one D&E site, only two misoprostol
doses were taken prior to admission. When deemed
necessary by the doctor or nurse, additional doses were
given, up to a maximum of eight. D&E was performed
using paracervical block with 20 cc of 1% lidocaine.
The medical induction sites also followed somewhat
different regimens of misoprostol. The initial misopros-
tol dose was either 600 mcg administered vaginally or
400 mcg taken orally. Thereafter, misoprostol 400 mcg
was administered orally every four hours. The median
Table 1 Participant characteristics
Characteristic D&E
1
(n = 220)
Medical
induction
(n = 84)
P value
Age (years) 0.523
18-25 112 (51%) 47 (56%)
26-35 89 (41%) 33 (39%)
>35 17 (8%) 5 (5%)
Education (Grade) 0.765
< Gr 12 107 (49%) 35 (47%)
Gr 12 110 (51%) 39 (53%)
Parity
0 49 (23%) 15 (18%) 0.167
1 78 (36%) 40 (48%)
> = 2 91 (42%) 29 (35%)
Gestational age on admission
(weeks)
<0.001
12.1-16.0 144 (66%) 12 (14%)
16.1-18.0 47 (22%) 27 (32%)
18.1-20.9 28 (13%) 45 (54%)
Prior vaginal delivery 149 (68%) 58 (78%) 0.101
Prior Caesarean Section 21 (10%) 5 (7%) 0.453
Prior Abortion 6 (3%) 5 (7%) 0.118
Housing 0.801
Formal (House or Flat) 142 (65%) 47 (64%)
Informal (Shack) 76 (35%) 27 (37%)
Persons per room 0.550
< = 2 175 (80%) 57 (68%)
>2 43 (20%) 17 (23%)
Languages spoken
Xhosa 148 (68%) 52 (70%) 0.703
English 57 (26%) 18 (24%) 0.757
Afrikaans 60 (28%) 5 (7%) <0.001
Paid for Work 74 (34%) 28 (38%) 0.596
1 D&E Dilation and evacuation
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D&E
(n = 220)
Medical induction
(n = 84)
P value
Total number of clinic or hospital visits related to abortion (N, %) <0.001
1 0 (0%) 1 (1.4%)
2 54 (25.1%) 8 (10.8%)
3 117 (54.4%) 17 (23.0%)
4 or more 44 (20.5%) 48 (64.9%)
Number of days between first clinic or hospital visit and abortion admission (Median, IQR)
2 17 (8 - 30) 30 (21-56) <0.001
Gestational age in weeks at time of ultrasound (weeks)
a (Median, IQR) 14.0 (13.0 - 15.4) 13.9 (11.9 - 15.4) 0.045
< = 12 weeks at time of ultrasound (N, %) 13 (8.1%) 24 (30.0%) <0.001
Number of days between ultrasound and abortion admission (Median, IQR)
a 6 (2 - 9) 31 (12 - 41) <0.001
2 Inter-quartile Range
a Data available for 161 D&E clients and 80 medical induction clients
Table 3 Procedure details, efficacy and immediate complications
D&E
(n = 203)
Medical induction
(n = 84)
P value
Length of surgical procedure (Median, IQR) 10 minutes
(5-10 minutes)
N/A
3
Time from 1st dose misoprostol to completion of TOP
(Median, IQR)
13.3 hrs (12.1-15.1) 23 hours
(17-30)
<0.001
Number of misoprostol doses (Median, IQR) 3 (3-3) 5 (3-5) <0.001
Medications received
Antibiotics 14 (7%) 65 (77%) <0.001
Analgesics/anxiolytics 38 (19%) 18 (21%) 0.585
Antiemetics 0 (0%) 7 (8%) <0.001
Efficacy
a 202 (99.5%)
(95% CI: 97.29% - 99.98%)
42 (50%)
(95% CI: 39.4% - 60.6%)
<0.001
Major Complications
Hemorrhage requiring transfusion 0 (0.0%) 3 (2.4%) 0.024
Minor Complications
Hemorrhage not requiring transfusion 0 (0%) 1 (1%) 0.293
Fever >38 degrees C 0 (0%) 1 (1%) 0.293
Additional curettage performed 0 (0%) 40 (48%) < 0.001
Incomplete abortion, absconded prior to treatment 0 (0%) 1 (1%) 0.293
Transfer to another facility to complete abortion 1 (1%) 1 (1%) 0.500
Expulsion of fetus prior to D&E 87 (43%) N/A N/A
Any minor complication 88 (43%) 42 (50%) 0.362
Any major or minor complication 88 (43%) 44 (52%) 0.193
3 Not applicable
a Efficacy was defined as complete abortion performed on-site with no need for repeat surgical procedure in the case of D&E, or no need for any surgical
intervention in the case of medical induction
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3-5), however the maximum number of doses was as
high as 36. When indicated, sharp or suction curettage
was performed.
Although frequently provided to induction clients
(77.4%) prophylactic antibiotics were rarely given to
D&E clients (6.9%). Only 18.6% of D&E clients and
21.4% of induction clients received either analgesics or
anxiolytics. Antiemetics were provided to a small num-
ber of induction clients (8.3%).
D&E was significantly more effective than induction;
only one D&E client with clinical data required transfer
to another facility because of inadequate cervical dilation
(efficacy 99.5%, 95% CI 97.3-99.98%). Among 84 induc-
tion clients, 40 required curettage for incomplete abor-
tion, one was diagnosed with incomplete abortion but
left the hospital before having the procedure, and one
was transferred to another facility because of a failed
induction (efficacy 50.0%, 95% CI 39.4-60.6%). Of the 40
cases of incomplete abortion, 36 (90%) were treated
with sharp curettage, 2 (5%) with suction curettage and
2 (5%) with other procedures. It is important to note,
however, that we were not able to collect information
about incomplete abortion after either procedure that
might have required delayed re-aspiration after hospital
discharge.
As shown in Table 3, the only major immediate com-
plications were three cases of hemorrhage requiring
transfusion. Major complications were significantly more
prevalent after induction compared to D&E, as they all
occurred among induction clients (p = 0.024). The pre-
valence of minor immediate complications, however,
was similar between the procedures. Fetal expulsion
prior to surgery was observed among 42.9% of D&E cli-
ents and was especially frequent at the sites that
initiated misoprostol for cervical priming the night prior
to the abortion. In addition to the cases of failed and
incomplete abortion mentioned above, one induction
client had hemorrhage that did not require transfusion,
and one had a fever.
Of the 80 D&E clients who expelled the fetus prior to
the procedure and answered the question, 42 (52.5%)
expelled it at home, 4 (5%) during transport, and the
r e m a i n d e r( 4 2 . 5 % )e x p e l l e da tt h eh o s p i t a l .U p o nn o t i -
cing the fetal expulsion, women reported feeling scared
(32.5%), surprised (30%), sad (13.8%) or other emotions;
16.3% expressed relief that the abortion was successful
and complete.
I n f o r m a t i o no nw o m e n ’s symptoms and acceptability
of the procedures is shown in Table 4. Women under-
going D&E reported significantly higher pain levels than
those undergoing induction (p = 0.001). The prevalence
of other symptoms was similar for both groups. Signifi-
cantly more D&E clients reported high levels of
emotional discomfort associated with the abortion com-
pared with induction clients, although most clients (>
84%) were satisfied with the emotional support received
during the procedure. Overall, there were very high
levels of satisfaction with both abortion procedures, and
the majority of women (73%) said that they would
recommend their method to a friend who needed a sec-
ond trimester abortion.
Discussion
This is the first comparative study documenting D&E
and medical induction services in a developing country
setting, and the first in South Africa, where second tri-
mester abortions are more prevalent than other coun-
tries. Despite the different context, our findings on the
safety and efficacy of D&E and second trimester medical
induction are similar to those reported in more devel-
oped country settings [4-8,17]. Both D&E and medical
induction are being provided safely in this context,
although induction frequently required curettage to
complete the procedure and had a higher proportion of
major immediate complications. The association of
induction with hemorrhage requiring transfusion is con-
cerning and merits further research; a similar trend was
observed in a review of case series [9], while a large reg-
istry study from Finland found no increased risk of
hemorrhage with second trimester medical induction
compared to first trimester medical abortion [17].
Compared to the D&E services, the medical induction
services had limited capacity, as demonstrated by the
smaller number of induction cases performed during the
study period. The limited capacity of this service likely
contributed to the delays between presentation and
abortion that we documented among induction clients,
although there may have been other reasons as well.
Prior research in South Africa found that women seek-
ing second trimester abortion reported structural bar-
riers within the public health system as factors that
contributed to presenting later in pregnancy [18]. Every
additional week of gestation confers a significant
increase in the risk of mortality with abortion [19], and
it is critical that health systems work to improve the
referral process to minimize these delays. It is particu-
larly concerning that almost one third of induction cli-
ents were in the first trimester at the time of their
ultrasound, when they would have been eligible for a
manual vacuum aspiration (MVA) procedure performed
by a midwife or nurse.
Taken together, these findings suggest that D&E
might be the superior method to provide second trime-
ster abortion in South Africa and similar settings. D&E
using MVA has been introduced successfully in Vietnam
[20] and Nepal [21]. However, there is a critical shortage
of trained D&E providers in South Africa, and doctors
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Investments in training, including pre-service training in
medical school, as well as values clarification exercises
with physicians [23] are needed to create a cadre of
skilled D&E providers in this country.
Our results highlight several areas for improvement in
the second trimester abortion services in the Western
Cape. We found that 43% of D&E clients expelled the
fetus prior to the procedure, which was frequently trau-
matic for women, and this was likely related to the
r e p e a t e dd o s e so fm i s o p r o s t o lg i v e na sm u c ha s1 2
hours before the procedure. Indeed, for the women who
experienced fetal expulsion, their abortion procedure
was more similar to medical induction than D&E.
Although there is limited published evidence on the use
of misoprostol instead of osmotic dilators for cervical
preparation before D&E, a single dose of 400 mcg is the
most commonly studied regimen [24]. More research is
needed on cervical priming protocols appropriate for
settings where laminaria are not easily accessible, as is
the case in South Africa. The prolonged cramping asso-
ciated with misoprostol prior to D&E might also
account for the higher pain levels reported by women
undergoing this procedure compared to induction, as
well as the fact that few D&E clients received analgesia.
In contrast, both RCTs found that induction clients
reported significantly more pain than D&E clients,
although women in the latter group received general
anesthesia in both studies [5,6]. It is concerning that
analgesia use was low at all but one of the study sites.
Table 4 Symptoms and acceptability of abortion experience
D&E
(n = 220)
Medical induction
(n = 84)
P value
Overall pain during entire abortion experience 0.001
Extreme pain 75 (34%) 23 (31%)
High pain 50 (23%) 10 (14%)
Moderate pain 40 (18%) 11 (15%)
Slight pain 38 (17%) 11 (15%)
No pain 15 (7%) 19 (26%)
Symptoms reported
Nausea 15 (7%) 2 (3%) 0.255
Vomiting 57 (26%) 23 (31%) 0.452
Dizziness 63 (29%) 25 (34%) 0.465
Diarrhea 83 (38%) 40 (54%) 0.020
Tiredness 107 (49%) 40 (54%) 0.575
Pain in lower abdomen 214 (98%) 74 (100%) 0.573
Breast tenderness 106 (49%) 25 (34%) 0.031
Headache 84 (39%) 27 (37%) 0.783
Cold 89 (41%) 29 (39%) 0.891
Sweating/hot/fever 13 (6%) 3 (4%) 0.769
Other symptoms 31 (14%) 2 (3%) 0.005
Overall emotional discomfort with abortion 0.017
Moderate, high or extreme discomfort 108 (50%) 25 (34%)
None or slight discomfort 109 (50%) 49 (66%)
Overall satisfaction with abortion 1.000
Very or somewhat satisfied 207 (95%) 71 (96%)
Neutral or somewhat or very dissatisfied 11 (5%) 3 (4%)
Would recommend the abortion method to a friend who needed one at same gestational age 0.995
Highly or somewhat agree 159 (73%) 54 (73.0%)
Neutral or somewhat or highly disagree 59 (27%) 20 (27%)
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ment with second trimester abortion, research is needed
to understand clinicians’ reluctance to provide analgesia,
which may be related to punitive attitudes toward
abortion.
The medical induction protocol used in study sites
had low efficacy compared to published studies using
repeated vaginal or sublingual doses of misoprostol [25].
In addition, using mifepristone together with misopros-
tol has been demonstrated to significantly improve effi-
cacy and reduce the induction time [2]. Mifepristone is
not registered in South Africa for use in the second tri-
mester and is therefore not available in public hospitals
for this indication. We also found that sharp curettage
was used almost exclusively in cases of incomplete abor-
tion, despite the evidence supporting the superiority of
suction curettage for this indication [3].
This study has several limitations. The observational
nature of the study may have biased our findings,
although it is important to stress that women’s alloca-
tion to treatment was related to place of residence and
hospital catchment area, rather than personal choice.
Still, unmeasured differences between the populations
undergoing the two procedures might have accounted
for some of the observed differences. Comparison
between the two abortion methods is also made difficult
by the fact that a standardized protocol was not used in
all sites. A randomized controlled trial of D&E and
medical induction of sufficient size is needed to better
compare these methods, although both published RCTs
have found that recruitment for such a study is difficult
[5,6]. Another limitation relates to our lack of follow-up
and inability to capture delayed complications. This is
especially true of women undergoing D&E, since they
were observed for a relatively short period of time.
More research is needed on the long-term complications
of both of these methods. Due to the high volume of
procedures performed on days that the D&E service
operated, we were only able to enroll a smaller percent
of all D&E cases (29.5%) compared to all medical induc-
tion cases (50%). However, the D&E sample is represen-
tative of all three D&E providers in the Western Cape
and is sufficiently large to be representative of the D&E
service overall. Finally, while our study sites are likely
representative of the Western Cape, we cannot general-
ize beyond this province to other areas of South Africa
or other countries.
Conclusion
In the decade since legalizing abortion, South Africa has
made important advances in reducing abortion-related
morbidity and mortality [26,27]. This study shows that
currently in the Western Cape, second trimester abor-
tions by D&E were more effective than medical
procedures, required shorter hospital stay, had fewer
major immediate complications and were associated
with shorter delays accessing care. The delays for
women undergoing medical induction were so long that
they appeared to push some women into the second tri-
mester even though they initially presented during the
first trimester.
Second trimester abortion services are particularly
challenging due to the training investments that are
required. While clinical trial data from more developed
countries can be useful to guide the implementation of
services, it is critical that information about local capa-
city and resources also be considered. Because access to
good quality second trimester services is an essential
part of safe abortion services [28], implementing the ser-
vice changes described here could serve as a model for
other countries that are beginning to offer later abortion
care. In addition, more efforts are needed to expand
access to contraception, pregnancy testing and first tri-
mester abortion, including medication abortion, in order
to reduce the proportion of abortions performed in the
second trimester in South Africa.
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